LFCR

LIFECORE BIOMEDICAL, INC. \DE\

Healthcare · Drug Manufacturers - Specialty & Generic

$199.33 sample

+1.50 (+0.76%) 1D

Market cap

$115.2B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-08

Alerts

8

Price$199.33 +13.79% 3M daily closessample

202.69175.18

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 08SEC8-K filed: material event
Oct 02INSInsider sell: Director
Sep 28INSInsider sell: EVP, Operations
Sep 22INSInsider buy: General Counsel
Sep 16INSInsider buy: Chief Executive Officer
Sep 09SECDEF 14A filed
Aug 31INSInsider sell: EVP, Operations
Aug 20INSInsider sell: 10% owner

Sign up to see the real LFCR record →

Company facts

SEC EDGAR registration

Name: LIFECORE BIOMEDICAL, INC. \DE\
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Smart-money score: -27sample, -100 to +100
Reporting currency: USD

Who is positioning in LFCR

sample

Insiders: 15 insider transactions over 90 days, net selling, $387.6M
Congress: No member trades over 90 days
Institutions · 13F: 38 funds hold $2.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$3.1B +21.4% y/y

Q4 2024Q3 2026

Inventory$1.7B +5.1% y/y

Q4 2024Q3 2026

Accounts receivable$1.4B +10.5% y/y

Q4 2024Q3 2026

Total debt$3.6B +10.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $109.4B -12.9% 3M
Sample peer B: $63.0B +1.8% 3M
Sample peer C: $99.0B -13.2% 3M
Sample peer D: $99.1B +16.0% 3M
Sample peer E: $40.9B +9.2% 3M